Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
AstraZeneca
Express Scripts
Mallinckrodt
Boehringer Ingelheim

Last Updated: February 3, 2023

CLINICAL TRIALS PROFILE FOR FETZIMA


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Fetzima

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02265367 ↗ Novel Medication as a Potential Smoking Cessation Aid Completed University of Minnesota Early Phase 1 2015-01-01 The purpose of this study is to provide preliminary information assessing if levomilnacipran may be effective at increasing smoking cessation rates.
NCT02265367 ↗ Novel Medication as a Potential Smoking Cessation Aid Completed University of Minnesota - Clinical and Translational Science Institute Early Phase 1 2015-01-01 The purpose of this study is to provide preliminary information assessing if levomilnacipran may be effective at increasing smoking cessation rates.
NCT02288325 ↗ A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder Completed Forest Laboratories Phase 4 2014-11-18 This study evaluates the efficacy, safety and tolerability of levomilnacipran extended-release (ER) compared with placebo in the prevention of depression relapse in major depressive disorder (MDD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Fetzima

Condition Name

Condition Name for Fetzima
Intervention Trials
Major Depressive Disorder 4
Depressive Disorder, Major 1
Major Depressive Disorder (MDD) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Fetzima
Intervention Trials
Depressive Disorder, Major 5
Depressive Disorder 5
Depression 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Fetzima

Trials by Country

Trials by Country for Fetzima
Location Trials
United States 50
Canada 1
Puerto Rico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Fetzima
Location Trials
Georgia 3
California 3
New York 2
Alabama 2
Arizona 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Fetzima

Clinical Trial Phase

Clinical Trial Phase for Fetzima
Clinical Trial Phase Trials
Phase 4 4
Phase 3 2
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Fetzima
Clinical Trial Phase Trials
Completed 5
Active, not recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Fetzima

Sponsor Name

Sponsor Name for Fetzima
Sponsor Trials
Forest Laboratories 3
University of California, Los Angeles 1
Institute for Advanced Medical Research, Alpharetta, GA 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Fetzima
Sponsor Trials
Other 9
Industry 4
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Johnson and Johnson
AstraZeneca
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.